Eicosapentaenoic acid promotes mitochondrial biogenesis and beige-like features in subcutaneous adipocytes from overweight subjects

• Published in: The Journal of nutritional biochemistry Vol. 37; pp. 76 - 82
• Main Authors: Laiglesia, L.M., Lorente-Cebrián, S., Prieto-Hontoria, P.L., Fernández-Galilea, M., Ribeiro, S.M.R., Sáinz, N., Martínez, J.A., Moreno-Aliaga, M.J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-11-2016
• Subjects: Acyl-CoA Oxidase - chemistry; Acyl-CoA Oxidase - genetics; Acyl-CoA Oxidase - metabolism; Adipocytes, Beige - enzymology; Adipocytes, Beige - metabolism; Adipocytes, Beige - pathology; Adipocytes, White - enzymology; Adipocytes, White - metabolism; Adipocytes, White - pathology; Adipogenesis; Biomarkers - metabolism; Body Mass Index; Browning; Carnitine O-Palmitoyltransferase - chemistry; Carnitine O-Palmitoyltransferase - genetics; Carnitine O-Palmitoyltransferase - metabolism; Cells, Cultured; Diacylglycerol O-Acyltransferase - antagonists & inhibitors; Diacylglycerol O-Acyltransferase - genetics; Diacylglycerol O-Acyltransferase - metabolism; Eicosapentaenoic Acid - metabolism; Energy Metabolism; EPA; Fatty acid oxidation; Fatty Acid Synthases - antagonists & inhibitors; Fatty Acid Synthases - genetics; Fatty Acid Synthases - metabolism; Female; Gene Expression Regulation, Enzymologic; Humans; Lipid Metabolism; Lipogenesis; Mitochondrial biogenesis; Mitochondrial Dynamics; N-3 PUFAs; Organelle Biogenesis; Osmolar Concentration; Stearoyl-CoA Desaturase - antagonists & inhibitors; Stearoyl-CoA Desaturase - genetics; Stearoyl-CoA Desaturase - metabolism; Subcutaneous Fat, Abdominal - enzymology; Subcutaneous Fat, Abdominal - metabolism; Subcutaneous Fat, Abdominal - pathology; Fatty acid oxidation; N-3 PUFAs; Browning; Mitochondrial biogenesis; Lipogenesis; EPA
• ISSN: 0955-2863; 1873-4847
• DOI: 10.1016/j.jnutbio.2016.07.019

Eicosapentaenoic acid (EPA), a n-3 long-chain polyunsaturated fatty acid, has been reported to have beneficial effects in obesity-associated metabolic disorders. The objective of the present study was to determine the effects of EPA on the regulation of genes involved in lipid metabolism, and the ability of EPA to induce mitochondrial biogenesis and beiging in subcutaneous adipocytes from overweight subjects. Fully differentiated human subcutaneous adipocytes from overweight females (BMI: 28.1–29.8kg/m2) were treated with EPA (100–200 μM) for 24 h. Changes in mRNA expression levels of genes involved in lipogenesis, fatty acid oxidation and mitochondrial biogenesis were determined by qRT-PCR. Mitochondrial content was evaluated using MitoTracker® Green stain. The effects on peroxisome proliferator-activated receptor gamma, co-activator 1 alpha (PGC-1α) and AMP-activated protein kinase (AMPK) were also characterized. EPA down-regulated lipogenic genes expression while up-regulated genes involved in fatty acid oxidation. Moreover, EPA-treated adipocytes showed increased mitochondrial content, accompanied by an up-regulation of nuclear respiratory factor-1, mitochondrial transcription factor A and cytochrome c oxidase IV mRNA expression. EPA also promoted the activation of master regulators of mitochondrial biogenesis such as sirtuin 1, PGC1-α and AMPK. In parallel, EPA induced the expression of genes that typify beige adipocytes such as fat determination factor PR domain containing 16, uncoupling protein 1 and cell death-inducing DFFA-like effector A, T-Box protein 1 and CD137. Our results suggest that EPA induces a remodeling of adipocyte metabolism preventing fat storage and promoting fatty acid oxidation, mitochondrial biogenesis and beige-like markers in human subcutaneous adipocytes from overweight subjects.
[Display omitted]